Immune Boosting Drugs Show Promise in Treatment of Hodgkin’s

December 8, 2014 3:52 AM

15 0

Encouraging results have been obtained for drugs by Bristol-Myers Squibb Co. and Merck & Co. for treating Hodgkin’s lymphoma.

The drug acts by boosting the immune system by blocking a pathway called PD-1 and fight the cancer cells which managed to evade the natural defenses of the body. Another Merck’s drug, Keytruda has been given approval by the FDA to treat melanoma, one of the deadliest forms of skin cancer.

Read more

To category page